You are here

Envarsus

District Court Rules for FDA in Battle Over the Scope of 3-Year Exclusivity in the Context of Dueling Tacrolimus NDAs

FDA Law Blog

Wed, 06/17/15 - 06:36 pm

kidney transplants

Veloxis Pharmaceuticals submits NDA to US FDA to market Envarsus for kidney transplant recipients

Pharmabiz.com

Tue, 12/31/13 - 11:36 am

kidney translants